PFS
ZYME icon

Prospera Financial Services’s Zymeworks ZYME Stock Holding History

Prospera Financial Services’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,972
Closed -$72K – 2661
2022
Q1 		$72K Buy
+10,972
New +$97.8K ﹤0.01% 1222
2020
Q4 		– Sell
-75
Closed -$3K – 1612
2020
Q3 		$3K Buy
+75
New +$2.58K ﹤0.01% 1421

Other funds holding ZYME

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Prospera Financial Services's ZYME Position: Q2 2022 in Review

Prospera Financial Services sold out of Zymeworks (ZYME) in Q2 2022, closing a stake of 10,972 shares — an estimated $72K sold.

Prospera Financial Services first reported a position in ZYME in Q3 2020 and held it in 2 quarters. The position peaked at $72K in Q1 2022. 113 funds tracked by Wall St. Rank hold ZYME as of Q2 2022.

  • Prospera Financial Services reported no remaining Zymeworks position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 10,972 Zymeworks shares in Q2 2022, an estimated $72K.
  • Prospera Financial Services first reported a position in Zymeworks in Q3 2020 and held it in 2 quarters.
  • Prospera Financial Services's Zymeworks position peaked at $72K in Q1 2022.
  • 113 funds tracked by Wall St. Rank held Zymeworks as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.